BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BPI-361175 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BPI-361175\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT05393466-2105@assetmemo.bio
DTSTAMP:20261121T005823Z
DTSTART;VALUE=DATE:20280130
DTEND;VALUE=DATE:20280131
SUMMARY:BPI-361175: Phase 1/2 readout est. (NCT05393466)
DESCRIPTION:BPI-361175\, phase 1/2\, Non-Small Cell Lung Cancer.\nStudy: BP
 I-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSC
 LC)\nEstimated primary completion: 30 January 2028. This is a ClinicalTria
 ls.gov estimate\, not a confirmed readout date\, and it can move.\nDrug pa
 ge: https://assetmemo.bio/drug/bpi-361175#upcoming-events\nRegistry record
 : https://clinicaltrials.gov/study/NCT05393466
URL:https://assetmemo.bio/drug/bpi-361175#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
